BioCentury
ARTICLE | Clinical News

Troxatyl troxacitabine: Phase I

February 5, 2001 8:00 AM UTC

U.S. researchers published in the Journal of Clinical Oncology results of an open-label U.S. Phase I trial of Troxatyl in 42 patients with refractory leukemias. Of 30 evaluable patients with acute mye...